Qisda Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Peter Chen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.3yrs |
| CEO ownership | 0.1% |
| Management average tenure | 3.3yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
Narrative Update • Apr 02
2352: Steady Fair Value And Refined Assumptions Will Support Future Upside
Analysts have kept Qisda's fair value view broadly unchanged, with only very small tweaks to inputs like the discount rate and future P/E. These adjustments feed into a steady NT$36.73 price target that signals continued confidence in their existing valuation framework.Narrative Update • Mar 19
2352: Higher Profitability Assumptions And Steady Fair Value Will Support Future Upside
Analysts kept their NT$36.73 price target for Qisda unchanged, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E that effectively offset one another in their updated model. Valuation Changes Fair Value: NT$36.73 is unchanged in the updated model, indicating no revision to the overall equity value per share.Narrative Update • Mar 04
2352: Stable Assumptions And Slightly Higher P E Will Support A Higher Share Price
Analysts have made a small upward adjustment to their Qisda price target to reflect updated assumptions around the discount rate and future P/E. They have kept their fair value estimate broadly unchanged at about NT$36.73 per share.Narrative Update • Feb 18
2352: Stable Assumptions And Lower Discount Rate Will Support A Higher Share Price
Analysts have modestly adjusted their price target on Qisda to NT$36.73, reflecting fine tuning of assumptions such as a slightly lower discount rate, stable revenue growth and profit margin expectations, and a marginally revised future P/E multiple. Valuation Changes Fair Value: NT$36.73 is unchanged, indicating the updated inputs leave the core valuation estimate essentially the same.
New Narrative • Feb 06
AI Hardware Delays And Medical Regulatory Risks Will Eventually Support A Gradual Turnaround
Catalysts About Qisda Qisda is a diversified electronics and solutions group with businesses spanning information technology hardware, medical equipment and services, smart business solutions and networking and communications. What are the underlying business or industry changes driving this perspective?Narrative Update • Feb 03
2352: Steady Assumptions And Higher Required Return Will Support A Higher Share Price
Analysts have kept their price target for Qisda steady at US$36.73. Modest tweaks to inputs such as the discount rate and assumed future P/E suggest only fine tuning rather than a shift in their underlying outlook.Narrative Update • Jan 19
2352: Stable Long Term Assumptions Will Support A Higher Future Share Price
Analysts have kept their Qisda fair value estimate steady at about $36.73 per share, with only very small model updates to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. Valuation Changes Fair Value: The intrinsic value estimate is unchanged at about NT$36.73 per share.Narrative Update • Jan 05
2352: Stable Assumptions And Earnings Outlook Will Support Stronger Share Price
Analysts have kept their price target for Qisda broadly in line with prior estimates. The changes reflect only very small model tweaks around discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major change in their view of the stock.Narrative Update • Dec 14
2352: Stable Earnings Outlook Should Support Stronger Future Share Price Performance
Analysts have raised their price target on Qisda modestly to reflect slightly lower discount rates and a marginally improved long term earnings outlook, while keeping fair value estimates effectively unchanged at around $36.73 per share. Valuation Changes Fair Value Estimate: Unchanged at approximately NT$36.73 per share, indicating no material revision in the intrinsic value assessment.Narrative Update • Nov 29
2352: Lower Profit Margins Will Give Way To Future Share Price Upside
Analysts have slightly revised their price target for Qisda downward from $37.80 to $36.73. This change is attributed to moderate adjustments to profit margin expectations and future earnings estimates.Narrative Update • Nov 15
2352: Earnings Strength and Higher Margins Will Support Upcoming Share Upside
Narrative Update: Qisda Analyst Price Target Revised Analysts have raised their price target for Qisda, increasing it from $37.80 to $37.80. This revision is based on slightly higher expected revenue growth and profit margins, along with a modest uptick in the discount rate and projected future price-to-earnings ratio.Narrative Update • Nov 01
2352: Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda Analyst Price Target Updated Analysts have made a minor adjustment to Qisda’s price target, keeping it steady at $37.80. Recent analysis indicates only incremental changes to underlying valuation metrics.Narrative Update • Oct 17
Investments In AIoT And Medical Services Will Boost Future Profitability
Analysts have maintained their price target for Qisda at $37.80, citing stable financial indicators and minimal changes to key valuation metrics as supporting rationale for holding their previous outlook. Valuation Changes Fair Value: Remained unchanged at NT$37.80.Narrative Update • Oct 03
Investments In AIoT And Medical Services Will Boost Future Profitability
Analysts have raised their price target for Qisda from $31 to approximately $37.80, citing an adjusted fair value estimate. Other core financial projections remain consistent.Narrative Update • Sep 17
Investments In AIoT And Medical Services Will Boost Future Profitability
The notable downward revision in Qisda’s consensus analyst price target is primarily driven by a significant decline in net profit margin and a slight decrease in future P/E, lowering fair value from NT$35.75 to NT$31.00. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly fallen from NT$35.75 to NT$31.00.Narrative Update • Sep 02
Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda’s higher consensus price target reflects a sharp increase in its expected future P/E ratio, signaling improved earnings growth prospects or investor confidence, raising fair value from NT$28.50 to NT$35.75. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly risen from NT$28.50 to NT$35.75.
New Narrative • Feb 21
Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda’s focus on AIoT and AI technologies may increase revenue streams and improve gross margins through innovation in smart automation solutions.Analysis Article • Mar 12
Qisda's (TWSE:2352) Weak Earnings May Only Reveal A Part Of The Whole Picture
The market wasn't impressed with the soft earnings from Qisda Corporation ( TWSE:2352 ) recently. We did some further...Analysis Article • Mar 09
Qisda Corporation Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next
Qisda Corporation ( TWSE:2352 ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...Analysis Article • Feb 29
Qisda (TWSE:2352) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analysis Article • Mar 15
Is Qisda Corporation (TPE:2352) A Smart Pick For Income Investors?
Dividend paying stocks like Qisda Corporation ( TPE:2352 ) tend to be popular with investors, and for good reason...Analysis Article • Feb 26
Qisda Corporation's (TPE:2352) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Qisda's (TPE:2352) stock is up by a considerable 32% over the past three months. However, we decided to pay attention...Analysis Article • Feb 08
These 4 Measures Indicate That Qisda (TPE:2352) Is Using Debt Reasonably Well
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analysis Article • Jan 24
Should You Use Qisda's (TPE:2352) Statutory Earnings To Analyse It?
It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. That...Analysis Article • Jan 09
Qisda (TPE:2352) Has Gifted Shareholders With A Fantastic 275% Total Return On Their Investment
When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...Analysis Article • Dec 25
We Like These Underlying Trends At Qisda (TPE:2352)
What are the early trends we should look for to identify a stock that could multiply in value over the long term...CEO
Peter Chen (64 yo)
12.3yrs
Tenure
Mr. Chi-Hong Chen, also known as Peter, is Non Executive Chairperson of BenQ BM Holding Cayman Corporation from March 22, 2024 and serves as its Director since May 27, 2013. Mr. Chen joined the BenQ BM Hol...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | no data | no data | 0.13% NT$ 49.9m | |
| President | no data | no data | no data | |
| VP, CFO & Accounting Officer | no data | no data | 0.038% NT$ 15.0m | |
| VP and Chief HR | 4.3yrs | no data | 0.015% NT$ 5.9m | |
| President of the Network Communication Business Unit | 2.3yrs | no data | no data | |
| Vice Chairman & Director | no data | no data | 0.045% NT$ 17.8m | |
| VP & President of the Medical Devices Products Group | no data | no data | no data | |
| GM of Manufacturing Operations & MD of Qisda China | 2.3yrs | no data | no data | |
| CIO | no data | no data | no data | |
| Chief Information Security Officer | 6.2yrs | no data | no data | |
| VP & GM of Information Technology Business Group | no data | no data | no data | |
| VP & GM of Commercial & Industrial Business Group | no data | no data | 0.0031% NT$ 1.2m |
3.3yrs
Average Tenure
Experienced Management: 2352's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 12.3yrs | no data | 0.13% NT$ 49.9m | |
| Vice Chairman & Director | 8.9yrs | no data | 0.045% NT$ 17.8m | |
| Director | 3yrs | no data | 0.000030% NT$ 11.9k | |
| Independent Director | 5.9yrs | no data | no data | |
| Independent Director | 5.9yrs | no data | no data | |
| Independent Director | 3yrs | no data | no data | |
| Independent Director | 3yrs | no data | no data | |
| Independent Director | 3yrs | no data | no data |
4.5yrs
Average Tenure
64yo
Average Age
Experienced Board: 2352's board of directors are considered experienced (4.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/07 08:00 |
| End of Day Share Price | 2026/05/07 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Qisda Corporation is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nicholas Teo | CLSA |
| Joey Cheng | Goldman Sachs |
| null null | KGI Securities Co. Ltd. |